Literature DB >> 20065332

The era of molecular and other non-culture-based methods in diagnosis of sepsis.

Nicasio Mancini1, Silvia Carletti, Nadia Ghidoli, Paola Cichero, Roberto Burioni, Massimo Clementi.   

Abstract

Sepsis, a leading cause of morbidity and mortality throughout the world, is a clinical syndrome with signs and symptoms relating to an infectious event and the consequent important inflammatory response. From a clinical point of view, sepsis is a continuous process ranging from systemic inflammatory response syndrome (SIRS) to multiple-organ-dysfunction syndrome (MODS). Blood cultures are the current "gold standard" for diagnosis, and they are based on the detection of viable microorganisms present in blood. However, on some occasions, blood cultures have intrinsic limitations in terms of sensitivity and rapidity, and it is not expected that these drawbacks will be overcome by significant improvements in the near future. For these principal reasons, other approaches are therefore needed in association with blood culture to improve the overall diagnostic yield for septic patients. These considerations have represented the rationale for the development of highly sensitive and fast laboratory methods. This review addresses non-culture-based techniques for the diagnosis of sepsis, including molecular and other non-culture-based methods. In particular, the potential clinical role for the sensitive and rapid detection of bacterial and fungal DNA in the development of new diagnostic algorithms is discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20065332      PMCID: PMC2806664          DOI: 10.1128/CMR.00043-09

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  214 in total

1.  Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay.

Authors:  L Louie; J Goodfellow; P Mathieu; A Glatt; M Louie; A E Simor
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

2.  False-positive Aspergillus antigen testing due to application of piperacillin/tazobactam--is it still an issue?

Authors:  Olaf Penack; Patricia Rempf; Barbara Graf; Eckhard Thiel; Igor Wolfgang Blau
Journal:  Diagn Microbiol Infect Dis       Date:  2007-09-21       Impact factor: 2.803

3.  Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii.

Authors:  Laura Rodero; Manuel Cuenca-Estrella; Susana Córdoba; Pedro Cahn; Graciela Davel; Sara Kaufman; Liliana Guelfand; Juan L Rodríguez-Tudela
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis.

Authors:  D Stynen; A Goris; J Sarfati; J P Latgé
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

5.  Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.

Authors:  Theoklis E Zaoutis; Kateri Heydon; Jaclyn H Chu; Thomas J Walsh; William J Steinbach
Journal:  Pediatrics       Date:  2006-03-13       Impact factor: 7.124

Review 6.  Diagnosis and management of bacterial infections in the neonate.

Authors:  Jeffrey S Gerdes
Journal:  Pediatr Clin North Am       Date:  2004-08       Impact factor: 3.278

7.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

8.  False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients.

Authors:  Jesus Fortún; Pilar Martín-Dávila; Maria E Alvarez; Francesca Norman; Aurora Sánchez-Sousa; Luis Gajate; Rafael Bárcena; S Javier Nuño; Santiago Moreno
Journal:  Transplantation       Date:  2009-01-27       Impact factor: 4.939

Review 9.  Invasive mold infections: recent advances in management approaches.

Authors:  Pranatharthi Chandrasekar
Journal:  Leuk Lymphoma       Date:  2009-05

10.  Detection of Aspergillus fumigatus-specific DNA, (1-3)-beta-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats.

Authors:  Z U Khan; S Ahmad; A M Theyyathel
Journal:  Mycoses       Date:  2008-03       Impact factor: 4.377

View more
  115 in total

1.  Use of a commercial PCR-based line blot method for identification of bacterial pathogens and the mecA and van genes from BacTAlert blood culture bottles.

Authors:  Mathis Steindor; Michael Weizenegger; Nicole Harrison; Alexander M Hirschl; Birgitta Schweickert; Ulf B Göbel; Colin R Mackenzie
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Improvement of detection of bacterial pathogens in normally sterile body sites with a focus on orthopedic samples by use of a commercial 16S rRNA broad-range PCR and sequence analysis.

Authors:  K Grif; I Heller; W M Prodinger; K Lechleitner; C Lass-Flörl; D Orth
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

3.  The potential for PCR based testing to improve diagnosis and treatment of sepsis.

Authors:  Ngan Lyle; John Boyd
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

4.  Diagnostic performance and therapeutic impact of LightCycler SeptiFast assay in patients with suspected sepsis.

Authors:  V Herne; A Nelovkov; M Kütt; M Ivanova
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-13

Review 5.  Droplet microfluidics for high-sensitivity and high-throughput detection and screening of disease biomarkers.

Authors:  Aniruddha M Kaushik; Kuangwen Hsieh; Tza-Huei Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-05-24

6.  Novel electrical method for early detection of viable bacteria in blood cultures.

Authors:  Sachidevi Puttaswamy; Byung Doo Lee; Shramik Sengupta
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

Review 7.  Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit.

Authors:  Patrick R Murray; Henry Masur
Journal:  Crit Care Med       Date:  2012-12       Impact factor: 7.598

8.  Diagnostic tools for tackling febrile illness and enhancing patient management.

Authors:  Konstantinos Mitsakakis; Valérie D'Acremont; Sebastian Hin; Felix von Stetten; Roland Zengerle
Journal:  Microelectron Eng       Date:  2018-10-05       Impact factor: 2.523

Review 9.  Advances and challenges in biosensor-based diagnosis of infectious diseases.

Authors:  Mandy L Y Sin; Kathleen E Mach; Pak Kin Wong; Joseph C Liao
Journal:  Expert Rev Mol Diagn       Date:  2014-02-13       Impact factor: 5.225

10.  Evaluation of the nanosphere verigene gram-positive blood culture assay with the VersaTREK blood culture system and assessment of possible impact on selected patients.

Authors:  Stacy G Beal; Jane Ciurca; Geremy Smith; Jeffrey John; Francesca Lee; Christopher D Doern; Rita M Gander
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.